ArticleJAMA oncology2022
Treatment for Advanced and Metastatic Thyroid Cancer Refractory to Standard Treatment-We Need to Know the When, What, and Who.
Electron KebebewPubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it